CAMP

MKT CAP:$210M

CAMP4 THERAPEUTICS CORPORATION

Market Cap

$210M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.11-$1.89 (-31.50%)

Jun 5, 2026

52W High $7.1352W Low $1.35

Company Details

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial fo...

CEO

—

IPO Date

Oct 11, 2024

Website

www.camp4tx.com

Key Metrics TTM

Revenue

$4M

+160.5% YoY

Net Income

-$86M

EPS (Diluted)

Free Cash Flow

-$26M

Revenue / Share

$0.07

Gross Margin

76.2%

Operating Margin

-1322.6%

Net Margin

-2193.7%

FCF Margin

-667.2%

P/S

53.3x

P/E

Earnings Reports

Q1 2026

May 7, 2026

$1M+50.8%

FY 2025

Mar 5, 2026

$3M+436.5%

Q4 2025

Mar 5, 2026

$348.0K-46.6%

Q3 2025

Nov 6, 2025

$795.0K

Q2 2025

Aug 14, 2025

$1M

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee